Custom iPSC Differentiation Service
Human induced pluripotent stem cells (iPSCs) have become a valuable tool for research, drug development, and regenerative medicine due to their ability to differentiate into various cell types. Creative Biolabs employs advanced technology to support scientists to have access to high-quality differentiated cells for their disease modeling and drug screening.
Our Workflow
The workflow for iPSC differentiation service typically involves several key steps to guide the differentiation of iPSCs into desired cell types for research use. While specific protocols may vary depending on the service provider and the target cell type, our general workflow can be outlined as follows:
Step 1 |
Consultation and Project Design Initial Consultation: Discuss objectives, cell types of interest, and desired deliverables with the service team. Project Customization: Define the specific requirements of the project, including any quality controls, and timelines. |
Step 2 |
iPSC Line Selection and Preparation Choosing a iPSC Line: Select from customer cell lines, our control iPSC lines and genetically engineered iPSCs that meet the project needs or use a custom line. iPSC Validation, Expansion, Adaptation: Validate the pluripotency of iPSCs, expand the validated cells for sufficient quantity, and adapt them to specific culture conditions for successful differentiation into target cell types. |
Step 3 |
iPSC Differentiation Protocol Development: Select or design a differentiation protocol tailored to the desired lineage (e.g., neurons, astrocytes, microglia). Adjust parameters based on specific needs, including growth factors and small molecules for directed differentiation. Differentiation: Initiate differentiation under controlled conditions using appropriate media and supplements. Regularly monitor cell morphology, growth, and expression of pluripotency and lineage-specific markers through microscopy and assays. |
Step 4 |
Cell Characterization Phenotypic Assessment: We perform rigorous quality control checks to confirm that differentiated neural cells are free from contaminants and express specific lineage markers with high viability post-thaw. Function Testing: For detailed functional characterization, we provide optional assays like microelectrode arrays, neurite outgrowth assays, and calcium transient assays to evaluate neuronal activity and functionality. |
Available Cell Lineages
We accommodate a diverse range of cell lineages, including neurons, astrocytes, and microglia among others. Below is a partial list of the lineages we provide. If you don't find a specific lineage you're looking for, we also offer tailored development of differentiation protocols for any unlisted lineages.
Neural Stem Cells | Neural Precursor Cells | Astrocytes | Microglia |
Oligodendrocytes | Cortical Neurons | Striatal Neurons | Peripheral Neurons |
Glutamatergic Neurons | GABAergic Neurons | Dopaminergic Neurons | Cholinergic Neurons |
Motor Neurons | Sensory Neurons | Brain Microvascular Endothelial Cells | |
Pericytes | Skeletal Muscle Cells | Smooth Muscle Cells | Schwann Cells |
Retinal Pigment Epithelial Cells | Monocytes | Macrophages | |
Cardiomyocytes | Hepatocytes | Photoreceptor Cells | Kidney Cells |
Case Study
Researchers used iPSCs from Researchers used iPSCs from Alzheimer's disease (AD) patients with different genetic backgrounds, edited them to create isogenic controls, and differentiated them into various cell types of the brain, such as neurons, oligodendrocytes, microglia, astrocytes, pericytes, and brain microvascular endothelial cells. These cells were cultured in 2D monoculture or 3D coculture, which greatly promoted the study of the role of APOE in the occurrence and development of AD.
Fig. 1 Employing iPSC-derived cells and 3D model to dissect the role of APOE in AD.1
Reference
- Pinals, Rebecca L, and Li-Huei Tsai. "Building in vitro models of the brain to understand the role of APOE in Alzheimer's disease." Sci Alliance. 2022 Dec 1;6(2):e202201845. Distributed under Open Access license CC BY 4.0 without modification.
- iNeuMab™ Anti-SEZ6 Antibody (NRP-0422-P515) (Cat#: NRP-0422-P515)
- iNeuMab™ Mouse Anti-LRP1 Monoclonal Antibody (CBP3363) (Cat#: NAB-0720-Z6479)
- iNeuMab™ Anti-F-Spondin/SPON1 Antibody, Clone 3F4 (Cat#: NRZP-0822-ZP4740)
- iNeuMab™ Anti-Alpha Synuclein BBB Shuttle Antibody (NRZP-1022-ZP4050) (Cat#: NRZP-1022-ZP4050)
- iNeuMab™ Anti-Tau Antibody (NRP-0422-P1686) (Cat#: NRP-0422-P1686)
- iNeuMab™ Anti-GARP Antibody (NRP-0422-P1639) (Cat#: NRP-0422-P1639)
- iNeuMab™ Rabbit Anti-Alpha-synuclein (CBP1631) (Cat#: NAB-08-PZ079)
- iNeuMab™ Anti-CD32b Antibody (NRP-0422-P1803) (Cat#: NRP-0422-P1803)
- iNeuMab™ Anti-CD20 Antibody (NRP-0422-P1230) (Cat#: NRP-0422-P1230)
- iNeuMab™ Anti-pTau Antibody (NRP-0422-P1719) (Cat#: NRP-0422-P1719)
- Rat Retinal Muller Cell Line, Immortalized (Cat#: NCL-21P6-192)
- Mouse Glioma Cell Line GL261 (Cat#: NCL-2108P28)
- Mouse Retinal Ganglion Cell Line RGC-5 (Cat#: NCL2110P154)
- Human Brain Astroblastoma U-87 MG (Cat#: NCL2110P117)
- Human Retinal Epithelial Cell ARPE-19 (Cat#: NCL2110P069)
- Mouse Microglia N9 (Cat#: NCL2110P073)
- Green Fluorescent BACE1 Cell Lines (Cat#: NCL2110P214)
- Rat Schwann Cells RSC96, Immortalized (Cat#: NCL-2108P21)
- iNeu™ Human Schwann Cell (Cat#: NCL-2103-P63)
- Rat Glioma Cell Line C6 (Cat#: NCL2110P346)
- Alpha-Synuclein Aggregation Assay Kit (Cat#: NRZP-1122-ZP37)
- Human Poly ADP ribose polymerase,PARP Assay Kit (Cat#: NRZP-1122-ZP62)
- Beta Amyloid (1-42), Aggregation Kit (Cat#: NRZP-0323-ZP200)
- Beta Amyloid (1-40), Aggregation Kit (Cat#: NRZP-0323-ZP199)
- Human GFAP ELISA Kit [Colorimetric] (Cat#: NPP2011ZP383)
- Human Tau Aggregation Kit (Cat#: NRP-0322-P2173)
- Amyloid beta 1-42 Kit (Cat#: NRP-0322-P2170)
- Alpha Synuclein Aggregation Kit (Cat#: NRZP-1122-ZP15)
- Dextran, NHS Activated (Cat#: NRZP-0722-ZP124)
- AAV2 Full Capsids, Reference Standards (Cat#: NTC2101070CR)
- AAV2/9-hEF1a-fDIO-eNpHR 3.0-mCherry-WPRE-pA (Cat#: NTA-2012-ZP78)
- VSV-eGFP (Cat#: NTA-2011-ZP20)
- Mouse SOD1 shRNA Silencing Adenovirus (Cat#: NV-2106-P14)
- Human superoxide dismutase 3, extracellular (SOD3) (NM_003102) ORF clone, Untagged (Cat#: NEP-0521-R0808)
- Tau Antisense Oligonucleotide (IONIS-MAPTRx) (Cat#: NV-2106-P29)
- Lenti of Human TAR DNA binding protein (TARDBP) (NM_007375) ORF clone, mGFP Tagged (Cat#: NEP-0521-R0832)
- Human superoxide dismutase 1, soluble (SOD1) (NM_000454) ORF clone, TurboGFP Tagged (Cat#: NEP-0521-R0748)
- Human presenilin 1 (PSEN1), transcript variant 2 (NM_007318) ORF clone, TurboGFP Tagged (Cat#: NEP-0421-R0140)
- Human huntingtin (HTT) (NM_002111) ORF clone, Myc-DDK Tagged (Cat#: NEP-0521-R0497)
- Lenti of Mouse synuclein, alpha (Snca) transcript variant (NM_001042451) ORF clone, mGFP Tagged (Cat#: NEP-0521-R0864)
- App Rat amyloid beta (A4) precursor protein (App)(NM_019288) ORF clone, Untagged (Cat#: NEP-0421-R0053)
- ABCA1 Antisense Oligonucleotide (NV-2106-P27) (Cat#: NV-2106-P27)
- NeuroBiologics™ Rat Cerebrospinal Fluid (Cat#: NRZP-0822-ZP496)
- NeuroBiologics™ Mouse Cerebrospinal Fluid (Cat#: NRZP-0822-ZP497)
- NeuroBiologics™ Pig Cerebrospinal Fluid (Cat#: NRZP-0822-ZP498)
- NeuroBiologics™ Monkey Cerebrospinal Fluid (Cat#: NRZP-0822-ZP495)
- NeuroBiologics™ Human Cerebrospinal Fluid (Cat#: NRZP-0822-ZP491)
- NeuroPro™ Anti-IDUA BBB Shuttle Protein (Cat#: NRZP-0423-ZP502)
- NeuroPro™ Anti-GDNF BBB Shuttle Protein (Cat#: NRZP-0423-ZP500)
- NeuroPro™ Anti-idursulfase BBB Shuttle Protein (Cat#: NRZP-0423-ZP497)
- NeuroPro™ Anti-Erythropoietin BBB Shuttle Protein (Cat#: NRZP-0423-ZP499)
- NeuroPro™ Anti-TNFR BBB Shuttle Protein (Cat#: NRZP-0423-ZP501)
- NeuroPro™ Anti-ASA BBB Shuttle Protein (Cat#: NRZP-0423-ZP504)
- NeuroPro™ Anti-PON1 BBB Shuttle Protein (Cat#: NRZP-0423-ZP507)
- NeuroPro™ Anti-SGSH BBB Shuttle Protein (Cat#: NRZP-0423-ZP505)
- NeuroPro™ Anti-NAGLU BBB Shuttle Protein (Cat#: NRZP-0423-ZP506)
- NeuroPro™ Anti-GDNF BBB Shuttle Protein (Cat#: NRZP-0423-ZP509)